GO:1903861

BP

positive regulation of dendrite extension

Any process that activates or increases the frequency, rate or extent of dendrite extension.

PARK2, SYT1, CPNE9, NEDD4L, ITSN2, RIMS2

GO:1903862

BP

positive regulation of oxidative phosphorylation

Any process that activates or increases the frequency, rate or extent of oxidative phosphorylation.

VCP, GADD45GIP1

GO:1903874

BP

ferrous iron transmembrane transport

The directed movement of ferrous iron (iron(2+)) across a membrane.

SLC11A2, SLC39A14, SLC25A37

GO:1903887

BP

motile primary cilium assembly

The aggregation, arrangement and bonding together of a set of components to form a motile primary cilium.

CENPJ, MKS1, CC2D2A, INTU

GO:1903891

BP

regulation of ATF6-mediated unfolded protein response

Any process that modulates the frequency, rate or extent of the ATF6-mediated unfolded protein response.

HSPA5

GO:1903894

BP

regulation of IRE1-mediated unfolded protein response

Any process that modulates the frequency, rate or extent of the IRE1-mediated unfolded protein response.

HSPA5

GO:1903896

BP

positive regulation of IRE1-mediated unfolded protein response

Any process that activates or increases the frequency, rate or extent of the IRE1-mediated unfolded protein response.

BCL2L11, BAX

GO:1903897

BP

regulation of PERK-mediated unfolded protein response

Any process that modulates the frequency, rate or extent of the PERK-mediated unfolded protein response.

HSPA5

GO:1903898

BP

negative regulation of PERK-mediated unfolded protein response

Any process that stops, prevents or reduces the frequency, rate or extent of the PERK-mediated unfolded protein response.

PPP1R15A

GO:1903899

BP

positive regulation of PERK-mediated unfolded protein response

Any process that activates or increases the frequency, rate or extent of the PERK-mediated unfolded protein response.

PTPN2

GO:1903900

BP

regulation of viral life cycle

Any process that modulates the frequency, rate or extent of viral life cycle.

LAMP3

GO:1903902

BP

positive regulation of viral life cycle

Any process that activates or increases the frequency, rate or extent of viral life cycle.

VPS4B

GO:1903911

BP

positive regulation of receptor clustering

Any process that activates or increases the frequency, rate or extent of receptor clustering.

TGFB1

GO:1903912

BP

negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation

Any process that stops, prevents or reduces the frequency, rate or extent of endoplasmic reticulum stress-induced eiF2alpha phosphorylation.

PPP1R15A, DNAJC3

GO:1903917

BP

positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation

Any process that activates or increases the frequency, rate or extent of endoplasmic reticulum stress-induced eIF2alpha dephosphorylation.

PPP1R15A

GO:1903919

BP

negative regulation of actin filament severing

Any process that stops, prevents or reduces the frequency, rate or extent of actin filament severing.

MYH9

GO:1903923

BP

positive regulation of protein processing in phagocytic vesicle

Any process that activates or increases the frequency, rate or extent of protein processing in phagocytic vesicle.

MYH9

GO:1903949

BP

positive regulation of atrial cardiac muscle cell action potential

Any process that activates or increases the frequency, rate or extent of atrial cardiac muscle cell action potential.

TRPM4

GO:1903955

BP

positive regulation of protein targeting to mitochondrion

Any process that activates or increases the frequency, rate or extent of protein targeting to mitochondrion.

LEPROT, FAM20B, ATG13, ABLIM3, ACTL6A, RNASE2, RAC2, ITGAX, HSPA1L, CTSK, RPL28, HNMT, NPEPPS, UBE2D3, MYBPC1, IL9R, NRG1, SREBF2, ZBTB17, HES1, UGCG, RHOU, HUWE1, UBE2J2, NKAP, BAP1, LRRC46, ZBED3, PINK1, EPT1, NBPF3, HPS4, STARD7, MIS18A, TOMM7, USP36, SAE1, PEMT, RUVBL1, SH3GLB1

GO:1903959

BP

regulation of anion transmembrane transport

Any process that modulates the frequency, rate or extent of anion transmembrane transport.

GPR89A, GPR89B, VDAC2, CLCN3, CLCN4, CLCN5, CLCN6, CLCN7, CLCNKA, CLCNKB, ANO6, VDAC3

GO:1903966

BP

monounsaturated fatty acid biosynthetic process

The chemical reactions and pathways resulting in the formation of monounsaturated fatty acid.

SCD

GO:1903984

BP

positive regulation of TRAIL-activated apoptotic signaling pathway

Any process that activates or increases the frequency, rate or extent of TRAIL-activated apoptotic signaling pathway.

ATF3, TIMP3, PTEN

GO:1903988

BP

ferrous iron export

The directed movement of iron(2+) out of a cell or organelle.

SLC40A1

GO:1903991

BP

positive regulation of ferrous iron import into cell

Any process that activates or increases the frequency, rate or extent of ferrous iron import into cell.

B2M, HFE

GO:1903999

BP

negative regulation of eating behavior

Any process that stops, prevents or reduces the frequency, rate or extent of eating behavior.

NAPEPLD

GO:1904017

BP

cellular response to Thyroglobulin triiodothyronine

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a Thyroglobulin triiodothyronine stimulus.

NCOA2, NCOA1

GO:1904031

BP

positive regulation of cyclin-dependent protein kinase activity

Any process that activates or increases the frequency, rate or extent of cyclin-dependent protein kinase activity.

CDKN1A

GO:1904036

BP

negative regulation of epithelial cell apoptotic process

Any process that stops, prevents or reduces the frequency, rate or extent of epithelial cell apoptotic process.

HMOX1

GO:1904037

BP

positive regulation of epithelial cell apoptotic process

Any process that activates or increases the frequency, rate or extent of epithelial cell apoptotic process.

JAK2, TIA1

GO:1904044

BP

response to aldosterone

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aldosterone stimulus.

CYBB, PARP1

GO:1904045

BP

cellular response to aldosterone

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aldosterone stimulus.

AIFM1

GO:1904046

BP

negative regulation of vascular endothelial growth factor production

Any process that stops, prevents or reduces the frequency, rate or extent of vascular endothelial growth factor production.

NUTF2

GO:1904049

BP

negative regulation of spontaneous neurotransmitter secretion

Any process that stops, prevents or reduces the frequency, rate or extent of spontaneous neurotransmitter secretion.

PARK2

GO:1904057

BP

negative regulation of sensory perception of pain

Any process that stops, prevents or reduces the frequency, rate or extent of sensory perception of pain.

IL10

GO:1904058

BP

positive regulation of sensory perception of pain

Any process that activates or increases the frequency, rate or extent of sensory perception of pain.

PTAFR, OPRL1

GO:1904059

BP

regulation of locomotor rhythm

Any process that modulates the frequency, rate or extent of locomotor rhythm.

OPRL1, ZFHX3

GO:1904071

BP

presynaptic active zone assembly

The aggregation, arrangement and bonding together of a set of components to form a presynaptic active zone.

PCDH17

GO:1904075

BP

positive regulation of trophectodermal cell proliferation

Any process that activates or increases the frequency, rate or extent of trophectodermal cell proliferation.

IGF1

GO:1904117

BP

cellular response to vasopressin

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vasopressin stimulus.

RANGAP1, CDC6

GO:1904153

BP

negative regulation of retrograde protein transport, ER to cytosol

Any process that stops, prevents or reduces the frequency, rate or extent of retrograde protein transport, ER to cytosol.

OS9, SVIP, DERL2

GO:1904154

BP

positive regulation of retrograde protein transport, ER to cytosol

Any process that activates or increases the frequency, rate or extent of retrograde protein transport, ER to cytosol.

BCAP31, EDEM1

GO:1904179

BP

positive regulation of adipose tissue development

Any process that activates or increases the frequency, rate or extent of adipose tissue development.

TRPM4, NR1H4

GO:1904199

BP

positive regulation of regulation of vascular smooth muscle cell membrane depolarization

Any process that activates or increases the frequency, rate or extent of regulation of vascular smooth muscle cell membrane depolarization.

TRPM4

GO:1904205

BP

negative regulation of skeletal muscle hypertrophy

Any process that stops, prevents or reduces the frequency, rate or extent of skeletal muscle hypertrophy.

IGFBP5

GO:1904209

BP

positive regulation of chemokine (C-C motif) ligand 2 secretion

Any process that activates or increases the frequency, rate or extent of chemokine (C-C motif) ligand 2 secretion.

POSTN

GO:1904211

BP

membrane protein proteolysis involved in retrograde protein transport, ER to cytosol

Any membrane protein proteolysis that is involved in retrograde protein transport, ER to cytosol.

HM13, RHBDD1

GO:1904219

BP

positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity

Any process that activates or increases the frequency, rate or extent of CDP-diacylglycerol-serine O-phosphatidyltransferase activity.

SERINC5, SERINC2, SERINC1

GO:1904222

BP

positive regulation of serine C-palmitoyltransferase activity

Any process that activates or increases the frequency, rate or extent of serine C-palmitoyltransferase activity.

SERINC5, SERINC2, SERINC1

GO:1904231

BP

positive regulation of succinate dehydrogenase activity

Any process that activates or increases the frequency, rate or extent of succinate dehydrogenase activity.

FXN

GO:1904234

BP

positive regulation of aconitate hydratase activity

Any process that activates or increases the frequency, rate or extent of aconitate hydratase activity.

FXN

GO:1904237

BP

positive regulation of substrate-dependent cell migration, cell attachment to substrate

Any process that activates or increases the frequency, rate or extent of substrate-dependent cell migration, cell attachment to substrate.

FN1

GO:1904240

BP

negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly

Any process that stops, prevents or reduces the frequency, rate or extent of VCP-NPL4-UFD1 AAA ATPase complex assembly.

SVIP

GO:1904246

BP

negative regulation of polynucleotide adenylyltransferase activity

Any process that stops, prevents or reduces the frequency, rate or extent of polynucleotide adenylyltransferase activity.

ZFP36

GO:1904247

BP

positive regulation of polynucleotide adenylyltransferase activity

Any process that activates or increases the frequency, rate or extent of polynucleotide adenylyltransferase activity.

PABPN1

GO:1904251

BP

regulation of bile acid metabolic process

Any process that modulates the frequency, rate or extent of bile acid metabolic process.

PANK2

GO:1904261

BP

positive regulation of basement membrane assembly involved in embryonic body morphogenesis

Any process that activates or increases the frequency, rate or extent of basement membrane assembly involved in embryonic body morphogenesis.

DAG1, PHLDB2, PHLDB1

GO:1904262

BP

negative regulation of TORC1 signaling

Any process that stops, prevents or reduces the frequency, rate or extent of TORC1 signaling.

SESN2, SESN3, STK11, RNF152, SESN1

GO:1904263

BP

positive regulation of TORC1 signaling

Any process that activates or increases the frequency, rate or extent of TORC1 signaling.

SEH1L

GO:1904268

BP

positive regulation of Schwann cell chemotaxis

Any process that activates or increases the frequency, rate or extent of Schwann cell chemotaxis.

TIAM1

GO:1904274

BP

tricellular tight junction assembly

The aggregation, arrangement and bonding together of a set of components to form a tricellular tight junction.

LSR

GO:1904283

BP

negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I

Any process that stops, prevents or reduces the frequency, rate or extent of antigen processing and presentation of endogenous peptide antigen via MHC class I.

HFE

GO:1904293

BP

negative regulation of ERAD pathway

Any process that stops, prevents or reduces the frequency, rate or extent of ERAD pathway.

USP25

GO:1904294

BP

positive regulation of ERAD pathway

Any process that activates or increases the frequency, rate or extent of ERAD pathway.

ATXN3, TMEM259, USP13

GO:1904300

BP

positive regulation of transcytosis

Any process that activates or increases the frequency, rate or extent of transcytosis.

PTAFR

GO:1904303

BP

positive regulation of maternal process involved in parturition

Any process that activates or increases the frequency, rate or extent of maternal process involved in parturition.

PTAFR

GO:1904306

BP

positive regulation of gastro-intestinal system smooth muscle contraction

Any process that activates or increases the frequency, rate or extent of gastro-intestinal system smooth muscle contraction.

PTAFR

GO:1904317

BP

cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine stimulus.

PTAFR

GO:1904322

BP

cellular response to forskolin

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a forskolin stimulus.

ADCY3, EFNA5, GNAI1

GO:1904338

BP

regulation of dopaminergic neuron differentiation

Any process that modulates the frequency, rate or extent of dopaminergic neuron differentiation.

DKK1, TIAM1

GO:1904339

BP

negative regulation of dopaminergic neuron differentiation

Any process that stops, prevents or reduces the frequency, rate or extent of dopaminergic neuron differentiation.

GSK3B

GO:1904352

BP

positive regulation of protein catabolic process in the vacuole

Any process that activates or increases the frequency, rate or extent of protein catabolic process in the vacuole.

CD81, RNF128

GO:1904354

BP

negative regulation of telomere capping

Any process that stops, prevents or reduces the frequency, rate or extent of telomere capping.

NBN, RAD50

GO:1904355

BP

positive regulation of telomere capping

Any process that activates or increases the frequency, rate or extent of telomere capping.

MAP2K7, TNKS, MAPK3, MAPK1, NEK2, PRKCQ, NEK7, AURKB, NABP2, TNKS2, MAP3K4

GO:1904356

BP

regulation of telomere maintenance via telomere lengthening

Any process that modulates the frequency, rate or extent of telomere maintenance via telomere lengthening.

OBFC1

GO:1904357

BP

negative regulation of telomere maintenance via telomere lengthening

Any process that stops, prevents or reduces the frequency, rate or extent of telomere maintenance via telomere lengthening.

TNKS, PARP1, TNKS2

GO:1904378

BP

maintenance of unfolded protein involved in ERAD pathway

Maintaining an endoplasmic reticulum (ER) protein in an unfolded, soluble state that contributes to its degradation by the cytoplasmic proteasome. Maintaining ER-resident proteins in an unfolded yet soluble state condition after their retro-translocation favors their turnover by the cytosolic proteasome.

USP13

GO:1904379

BP

protein localization to cytosolic proteasome complex involved in ERAD pathway

Any protein localization to cytosolic proteasome complex that is involved in ERAD pathway. Following their retrotranslocation out of the endoplasmic reticulum, protein substrates must be shuttled to the cytosolic proteasome for degradation.

ATXN3

GO:1904380

BP

endoplasmic reticulum mannose trimming

Any protein alpha-1,2-demannosylation that takes place in the endoplasmic reticulum quality control compartment (ERQC).

OS9, SYVN1, EDEM1, EDEM3, DERL2, UGGT1, SEL1L, MAN1B1

GO:1904381

BP

Golgi apparatus mannose trimming

Any protein alpha-1,2-demannosylation that takes place in the Golgi apparatus.

MAN1A1, MAN1C1

GO:1904382

BP

mannose trimming involved in glycoprotein ERAD pathway

The removal of one or more alpha 1,2-linked mannose residues from a mannosylated protein that occurs as part of glycoprotein ER-associated glycoprotein degradation (gpERAD).

EDEM1, EDEM3, MAN1B1

GO:1904383

BP

response to sodium phosphate

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a sodium phosphate stimulus.

HNRNPD

GO:1904385

BP

cellular response to angiotensin

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an angiotensin stimulus. Angiotensin is any of three physiologically active peptides (angiotensin II, III, or IV) processed from angiotensinogen.

HSF1, PRKCD, CDC6

GO:1904401

BP

cellular response to Thyroid stimulating hormone

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a Thyroid stimulating hormone stimulus.

RPLP0

GO:1904414

BP

positive regulation of cardiac ventricle development

Any process that activates or increases the frequency, rate or extent of cardiac ventricle development.

BMPR1A

GO:1904417

BP

positive regulation of xenophagy

Any process that activates or increases the frequency, rate or extent of xenophagy.

RIPK2, MAPK3, TBK1

GO:1904424

BP

regulation of GTP binding

Any process that modulates the frequency, rate or extent of GTP binding.

CSNK1A1, ARHGEF7

GO:1904426

BP

positive regulation of GTP binding

Any process that activates or increases the frequency, rate or extent of GTP binding.

CLN5, TGFB2

GO:1904428

BP

negative regulation of tubulin deacetylation

Any process that stops, prevents or reduces the frequency, rate or extent of tubulin deacetylation.

FRY

GO:1904430

BP

negative regulation of t-circle formation

Any process that stops, prevents or reduces the frequency, rate or extent of t-circle formation.

XRCC5

GO:1904431

BP

positive regulation of t-circle formation

Any process that activates or increases the frequency, rate or extent of t-circle formation.

ERCC1

GO:1904434

BP

positive regulation of ferrous iron binding

Any process that activates or increases the frequency, rate or extent of ferrous iron binding.

B2M, HFE

GO:1904437

BP

positive regulation of transferrin receptor binding

Any process that activates or increases the frequency, rate or extent of transferrin receptor binding.

B2M, HFE

GO:1904447

BP

folic acid import into cell

The directed movement of folic acid from outside of a cell, across the plasma membrane and into the cytoplasmic compartment. This may occur via transport across the plasma membrane or via endocytosis.

SLC46A1

GO:1904450

BP

positive regulation of aspartate secretion

Any process that activates or increases the frequency, rate or extent of aspartate secretion.

ABAT

GO:1904468

BP

negative regulation of tumor necrosis factor secretion

Any process that stops, prevents or reduces the frequency, rate or extent of tumor necrosis factor secretion.

NR1H4, SYT11

GO:1904469

BP

positive regulation of tumor necrosis factor secretion

Any process that activates or increases the frequency, rate or extent of tumor necrosis factor secretion.

HSPD1

GO:1904479

BP

negative regulation of intestinal absorption

Any process that stops, prevents or reduces the frequency, rate or extent of intestinal absorption.

HAMP

GO:1904482

BP

cellular response to tetrahydrofolate

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tetrahydrofolate stimulus.

SHMT1

GO:1904491

BP

protein localization to ciliary transition zone

A process in which a protein is transported to, or maintained in, a location within a ciliary transition zone.

TMEM107, CC2D2A

GO:1904501

BP

positive regulation of chromatin-mediated maintenance of transcription

Any process that activates or increases the frequency, rate or extent of chromatin-mediated maintenance of transcription.

CTNNB1